pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
LILLY · news · pharmadog
← back to LILLY
News mentioning LILLY
309
stories
23d
Opinion: Who benefits from classifying obesity as a disease?
stat
24d
Biohaven looks to take on Lilly in the muscle-sparing obesity space
endpoints
24d
STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
stat
25d
Tampa General kicks off legal fight over Lilly's 340B restrictions
endpoints
25d
Oberland pours up to $400M into MeiraGTx eye gene therapies
biopharma dive
25d
Kailera says obesity pill succeeds in late-stage trial in China
biopharma dive
25d
STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more
stat
26d
Gene editing developer Scribe plots an IPO
biopharma dive
26d
Novartis to acquire ADC developer in a deal worth up to $1.5B
biopharma dive
26d
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
stat
Jul 2, 26
STAT+: Medicare takes another swing at 340B cuts to hospitals
stat
Jul 2, 26
STAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals
stat
Jul 2, 26
STAT+: Elevance sues government over $115 million tied to Medicare Advantage star ratings
stat
Jul 2, 26
STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
stat
Jul 2, 26
The new presidential fitness test is a positive step, not the solution, experts say
stat
Jul 1, 26
STAT+: Booze schmooze: The alcohol industry, frazzled by headwinds, wields its power behind the scenes
stat
Jun 30, 26
Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot program
biopharma dive
Jun 30, 26
Republican Tom Kean Jr. reveals depression diagnosis after his four-month absence from Congress
stat
Jun 30, 26
Eli Lilly, Fujifilm among seven selected for FDA’s PreCheck pilot
endpoints
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Jun 30, 26
Half of states sue over Medicaid work requirements
stat
Jun 30, 26
STAT+: Even with MAHA, Trump administration has gone soft on alcohol
stat
Jun 30, 26
STAT+: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk
stat
Jun 29, 26
FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing
fda press
Jun 29, 26
STAT+: 26 states sue to block Medicaid work requirements
stat
Jun 29, 26
5 takeaways from STAT’s investigation into microhospital operator Nutex Health
stat
Jun 29, 26
STAT+: Longevity, wellness physicians named to panel advising FDA on peptides
stat
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 26, 26
FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences services
biopharma dive
Jun 26, 26
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
biopharma dive
← prev
page 5 of 11
next →
